2017 NLCRT Inaugural Meeting

2017 NLCRT Inaugural Meeting

2017 NLCRT Annual Meeting

December 11 – 12, 2017

Location: DoubleTree Hilton, Bethesda, MD

With the formal launch of the NLCRT in 2017, we held our inaugural meeting of the NLCRT members on December 11-12, 2017 in Bethesda, Maryland. Membership was composed of nearly 70 patient and policy advocacy organizations, government agencies, cancer centers, professional and medical societies, and corporate associates who engaged and energized NLCRT members to strive to reduce the incidence of and mortality from lung cancer. All aspects of the NLCRT and its membership were showcased through plenary and breakout sessions dedicated to lung cancer screening implementation, provide engagement and outreach, tobacco treatment in the context of lung cancer screening, shared decision-making, and access to optimal therapy.  

View Agenda

[vc_section css=”.vc_custom_1531493802456{background-color: #f4f4f4 !important;}”]

Featured Speakers

Ella Kazerooni, MD, MS
NLCRT Chair
University of Michigan

View Bio

Douglas Wood, MD
NLCRT Vice Chair
University of Washington

View Bio

Chris Draft
Founder, President, and CEO
The Chris Draft Family Foundation

View Bio

[/vc_section]

Agenda

[vc_tta_tabs color=”white” alignment=”center” active_section=”1″]

8:00 AM – 10:00 AM Registration
10:00 AM – 10:15 AM  Welcome

Richard Wender, MD, Co-Chair, National Colorectal Cancer Roundtable Chief Cancer Control Officer, American Cancer Society

Presentations:
The National Lung Cancer Roundtable:Now Is Our Moment – Richard C. Wender, MD

10:15 AM 11:05 AM Introducing the National Lung Cancer Roundtable

Ella Kazerooni, MD, MS, Chair, National Lung Cancer Roundtable, Professor, Radiology; Associate Chair, Clinical Affairs; Director, Cardiothoracic Radiology Division; Chair, Radiology’s Service Excellence Program; University of Michigan Douglas Wood, MD, Vice Chair, National Lung Cancer Roundtable Henry N. Harkins Professor and Chair, Department of Surgery, University of Washington

Presentations:
National Lung Cancer Roundtable – Ella A. Kazerooni, MD, MS, FACR, FSCBTMR
American Cancer Society National Lung Cancer Roundtable – Douglas E. Wood, MD, FACS, FRCSEd

11:05 AM – 11:30 AM  Roundtables: How and Why They Work

Robert Smith, PhD, Principal Investigator, National Lung Cancer Roundtable and Co-Chair, National Colorectal Cancer Roundtable Vice President, Cancer Screening, American Cancer Society

Presentations:
Roundtables: How and Why They Work – Robert A. Smith, PhD

11:30 AM – 12:00 PM  Keynote Address

Christopher Draft Founder, President & CEO The Chris Draft Family Foundation Team Draft

12:00 PM – 1:00 PM Buffet Lunch and Networking
1:00 PM – 3:40 PM

1:00 PM – 1:50 PM

Afternoon Plenary Session I

Plenary Sessions on the state of lung cancer control, current challenges and key, relevant recent literature, organized under Task Group themes. Each group will have time for presentations and Q&A.

Provider Engagement and Outreach Panel

Moderators: Chair: Thomas Houston, MD, Adjunct Professor, Department of Family Medicine, The Ohio State University College of Medicine Vice Chair: Ella Kazerooni, MD, MS, Professor of Radiology, University of Michigan

Plenary Speakers:

Thomas J. Van Hoof, MD, EdD Associate Professor University of Connecticut School of Nursing Provider Engagement and Changes in Practice Behavior that Incorporates Evidence-Based Clinical Guidelines for Lung Cancer Screening Jamie L. Studts, PhD  Professor, Department of Behavioral Science University of Kentucky College of Medicine Kentucky LEADS Collaborative and its Efforts on the Ground to Implement Lung Cancer Screening Guidelines

Presentations:
Early Efforts to Engage Clinicians Regarding Lung Cancer Screening in Kentucky – Jamie L. Studts, PhD
Evidence and Theory in Support of Guideline Implementation – Thomas J. Van Hoof, MD, EdD

1:55 PM – 2:45 PM Lung Cancer Screening Implementation Strategies Panel


Moderators:

Chair: Charles White, MD, Chief, Thoracic Radiology, University of Maryland Vice Chair: Peter Mazzone, MD, MPH, Director, Lung Cancer Program, Respiratory Institute, and Director, Lung Cancer Screening Program, Cleveland Clinic

Plenary Speakers:

Christopher Lathan, MD, MS, MPH Assistant Professor of Medicine, Harvard Medical School Medical Director, Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center Disparities and Challenges to Access from the Perspective of Lung Cancer Screening Implementation Jane Kim, MD, MPH Deputy Chief Consultant for Preventive Medicine Veterans Affairs National Center for Health Promotion and Disease Prevention Outcomes of the Veterans Health Administration Demonstration Project and the Implementation Challenges Faced Claudia Henschke, MD, PhD Clinical Professor, Radiology Director, Lung Screening Program Mount Sinai Medical Center Ensuring Access and Optimizing Implementation in the ELCAP Cohort Carey Thomson, MD, MPH Chief, Pulmonary and Critical Care Medicine Mt. Auburn Hospital American Lung Association/American Thoracic Society’s Lung Cancer Screening Implementation Guide and Toolkit

Presentations:
Lung Cancer Screening with Low Dose Computed Tomography in the Veterans Health Administration – Jane Kim, MD, MPH
Disparities and Challenges to Access from the Perspective of Lung Cancer Screening Implementation – Christopher Lathan MD MS MPH
ALA/ATS GUIDE AND WEB-BASED TOOLKIT FOR IMPLEMENTATION OF LUNG CANCER SCREENING – Carey Thomson, MD, MPH

2:50 PM – 3:40 PM Tobacco Cessation in the Context of Lung Cancer Screening Panel

Moderators:

Chair: Jamie Ostroff, PhD, Chief, Behavioral Sciences Service and Vice Chair for Research,    

Director, Tobacco Treatment Program, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering

Vice Chair: Peter Shields, MD, Professor, College of Medicine, Deputy Director,Comprehensive Cancer Center of Excellence in Regulatory Tobacco Science, The Ohio State University

Plenary Speakers: 

Hasmeena Kathuria, MD  Assistant Professor of Medicine Boston University School of Medicine Overview of Smoking Cessation in the Context of Lung Cancer Screening Elyse Park, PhD, MPH Associate Professor of Psychiatry Harvard Medical School/Massachusetts General Hospital NLST Findings Regarding Quitting Motivation and Attitudes Among High-Risk Smokers Seeking Lung Cancer Screening Steven Zeliadt, PhD, MPH Research Associate Professor of Health Services University of Washington School of Public Health VHA Findings Regarding Quitting Motivation and Attitudes among High-Risk Smokers Seeking Lung Cancer Screening

Presentations:
Overview: Integrating Smoking Cessation with Lung Cancer Screening – Hasmeena Kathuria, MD
NLST Findings Regarding Quitting Motivation & Attitudes – Elyse R. Park, Ph.D., MPH
Lung cancer screening & cessation motivation among current smokers: Snapshot of Screening in VA – Steven B. Zeliadt, PhD MPH

3:40 PM – 4:00 PM Afternoon Break
4:00 PM – 5:45 PM Afternoon Plenary Session II
4:00 PM – 4:50 PM Triage for Appropriate Treatment Panel

Moderators: Chair:

Gerard Silvestri, MD, MS, George Sr. and Margaret Hillenbrand Endowed Professor of Thoracic Oncology, Division of Pulmonary, Critical Care and Sleep Medicine, Medical University of South Carolina Vice Chair: Douglas Wood, MD, Henry N. Harkins Professor and Chair, Department of Surgery, University of Washington

Plenary Speakers: 

Elizabeth David, MD Assistant Professor of Surgery UC Davis Medical Center Disparities in Referral and Access to Lung Cancer Treatment Gerard Silvestri, MD, MS Variation in Guideline-directed Diagnosis & Treatment of Lung Cancer

Presentations:
Disparities in Lung Cancer Treatment – Elizabeth A David MD, MAS FACS
National Lung Cancer Roundtable: Triage for Appropriate Treatment – Gerard A. Silvestri MD,MS

4:55 PM – 5:45 PM Shared Decision-Making Panel

Moderators:  

Chair: Robert Volk, PhD, Department of Health Services Research, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center  

Vice Chair: Peter Mazzone, MD, MPH, Director, Lung Cancer Program, Respiratory Institute, and Director, Lung Cancer Screening Program, Cleveland Clinic

Plenary Speakers:

Robert Volk, PhD Overview of Shared Decision-Making Peter Mazzone, MD, MPH Incorporation of Shared Decision-Making into Cleveland Clinic’s Lung Cancer Screening Program Nichole Tanner, MD, MSCR  Associate Professor, Division of Pulmonary and Critical Care Medical University of South Carolina Delivery Methods of Shared Decision-Making in Lung Cancer Screening: The Potential for Outreach

Presentations:
Lung Cancer Screening Counseling and Shared Decision Making Visit – Peter Mazzone, MD, MPH
Delivery methods of shared decision making in LCS: the potential for outreach – Nichole T. Tanner, MD, MSCR
Overview of Shared Decision Making – Robert J. Volk, PhD

5:45 PM – 7:00 PM Reception Hosted by AstraZeneca
7:00 PM Dinner on your own

7:30 AM – 8:30 AM Networking Breakfast
8:30 AM – 11:15 AM Task Group Breakout Session Open House
Task Group Chairs, Vice Chairs, and participating members will discuss their goals for 2018, challenges/needs, and special projects in a collaborative format with NLCRT organization members.Meeting attendees are invited to participate in any and all Task Group Breakout Open House meetings.Lung Cancer Screening Implementation Strategies Task Group (Breakout Room A)
Provider Engagement & Outreach Task Group (Breakout Room B)
Shared Decision-Making Task Group (Breakout Room C)
Tobacco Cessation in the Context of Lung Cancer Screening Task Group (Breakout Room D)
Triage for Appropriate Treatment Task Group (Breakout Room E)
11:15 AM – 11:30 AM Break
11:30 AM – 12:30 PM Working Buffet Lunch
12:00 PM – 12:30 PM NLCRT Website Presentation by Ghost Note Agency
Brandon Ellis, CEO
12:30 PM – 3:00 PM Task Group Showcase
Each Task Group will share the product of the morning Open House breakout sessions with the NLCRT membership in a plenary session and report on challenges, needs, and goals for 2018.Provider Engagement and Outreach Task Group (12:30 – 1:00 PM)
Lung Cancer Screening Implementation Strategies Task Group (1:00 – 1:30 PM)
Tobacco Cessation in the Context of Lung Cancer Screening Task Group (1:30 – 2:00 PM)
Triage for Appropriate Treatment Task Group (2:00 – 2:30 PM)
Shared Decision-Making Task Group (2:30 – 3:00 PM)
3:00 PM – 3:15 PM Closing Thoughts
3:15 PM Adjourn

[/vc_tta_tabs]